eGFR vs CrCl: which renal function estimate should you use?

eGFR and Cockcroft-Gault creatinine clearance (CrCl) are different renal estimates. They use different equations, report different units and can produce different numbers. The important question is not “which one always wins?” but “which estimate and units does the current medicine or clinical source require?”

eGFR and CrCl at a glance

Why the numbers differ

The difference is not caused by one single factor. CKD-EPI and Cockcroft-Gault are different estimating equations, were developed for different purposes and populations, and handle patient characteristics differently. CKD-EPI eGFR is commonly indexed to 1.73 m² body surface area, while Cockcroft-Gault directly includes a selected body weight and reports mL/min.

Because of those structural differences, an eGFR value and a CrCl value from the same patient should not be expected to match exactly.

Indexed eGFR versus absolute mL/min

Laboratory eGFR is commonly reported in mL/min/1.73 m². For some medicine-dosing decisions, an absolute GFR estimate in mL/min may be needed. A common de-indexing calculation is: indexed eGFR × BSA ÷ 1.73.

A de-indexed eGFR is still an eGFR-based estimate. It does not become Cockcroft-Gault CrCl simply because both are expressed in mL/min.

Which one should you use?

Why the old “eGFR for CKD, CrCl for drugs” rule is too simple

CKD-EPI eGFR is central to CKD assessment and G-category classification, but current guidance also supports contemporary eGFR equations for many drug-dosing settings. At the same time, some medicines and situations still specifically require Cockcroft-Gault CrCl.

The National Kidney Foundation now recommends transitioning adult medication-related decisions toward race-free eGFR, with individual BSA adjustment when appropriate. FDA's 2024 renal-impairment guidance prefers eGFR over eCrCl specifically for pharmacokinetic studies. Existing product information and specialty protocols can still require Cockcroft-Gault or another method, so MedMaths routes the calculation according to the current governing source rather than publishing one universal substitution rule.

Both estimates have limitations

• Serum-creatinine equations are less reliable when creatinine is changing rapidly.
• Very low or high muscle mass, frailty, amputation and other factors can make creatinine less representative of filtration.
• Body size matters differently across indexed eGFR and weight-containing CrCl calculations.
• When a dosing decision sits close to an important threshold, the consequences of estimation error matter more.
• Creatinine-cystatin C eGFR is generally more accurate when both standardized markers are available, but it is not automatically best for every patient because non-GFR factors can affect one or both markers.
• When estimation remains unreliable and accuracy is critical, measured GFR or another method specified by the clinical source may be appropriate.

Calculate the estimate your source requires

If you are still deciding which calculation the source is asking for, start with the Choose renal function method hub rather than selecting an equation from memory.

Sources

• NIDDK: eGFR Equations for Adults
• NIDDK: Determining Drug Dosing in Adults with CKD
• National Kidney Foundation: Cockcroft-Gault limitations and medication-related transition guidance
• NKF Workgroup consensus on race-free eGFR for medication-related decisions
• KDIGO 2024 CKD guideline suite
• FDA 2024 renal-impairment pharmacokinetics guidance
• UK MHRA: appropriate renal-function estimate for prescribing
• NHS SPS: Calculating kidney function